Clinical applications of multiparametric MRI within the prostate cancer diagnostic pathway☆

[1]  Monish Aron,et al.  3-Dimensional elastic registration system of prostate biopsy location by real-time 3-dimensional transrectal ultrasound guidance with magnetic resonance/transrectal ultrasound image fusion. , 2012, The Journal of urology.

[2]  Mana Ishibashi,et al.  Detection and Localization of Prostate Cancer With the Targeted Biopsy Strategy Based on ADC Map: A Prospective Large-Scale Cohort Study , 2012, Journal of magnetic resonance imaging : JMRI.

[3]  Thomas Hambrock,et al.  Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. , 2012, European urology.

[4]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[5]  Christina Bougatsos,et al.  Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force , 2011, Annals of Internal Medicine.

[6]  G. Haber,et al.  Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging‐targeted and systematic biopsy for significant prostate cancer detection , 2011, BJU international.

[7]  Pingkun Yan,et al.  Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. , 2011, The Journal of urology.

[8]  Matthew R Cooperberg,et al.  Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Ralph Strecker,et al.  Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding--multiparametric MR imaging for detection and biopsy planning. , 2011, Radiology.

[10]  Yousef Mazaheri,et al.  Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. , 2011, Radiology.

[11]  Valeria Panebianco,et al.  Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. , 2011, European urology.

[12]  David J. Hawkes,et al.  Modelling Prostate Motion for Data Fusion During Image-Guided Interventions , 2011, IEEE Transactions on Medical Imaging.

[13]  B. Carey,et al.  Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. , 2011, European urology.

[14]  S. Verma,et al.  Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. , 2011, AJR. American journal of roentgenology.

[15]  A. Verbaeys,et al.  Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients. , 2011, European journal of radiology.

[16]  P. Choyke,et al.  D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. , 2010, The Journal of urology.

[17]  C. Lawton.  Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer , 2011 .

[18]  C. Parker,et al.  Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance. , 2011, The British journal of radiology.

[19]  C. de Bazelaire,et al.  BI-RADS categorisation of 2708 consecutive nonpalpable breast lesions in patients referred to a dedicated breast care unit , 2011, European Radiology.

[20]  R. Weersink,et al.  Real-time magnetic resonance imaging-guided focal laser therapy in patients with low-risk prostate cancer. , 2010, European urology.

[21]  Thomas Hambrock,et al.  Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. , 2010, The Journal of urology.

[22]  Alexandre Mamedov,et al.  Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  H. Honda,et al.  Prostate cancer detection: the value of performing an MRI before a biopsy , 2009, Acta radiologica.

[24]  P. Scardino,et al.  Prostatic transition zone directed needle biopsies uncommonly sample clinically relevant transition zone tumors. , 2009, The Journal of urology.

[25]  Peter Choyke,et al.  Challenges in clinical prostate cancer: role of imaging. , 2009, AJR. American journal of roentgenology.

[26]  J. Presti.  Repeat prostate biopsy--when, where, and how. , 2009, Urologic oncology.

[27]  Clare Allen,et al.  Is it time to consider a role for MRI before prostate biopsy? , 2009, Nature Reviews Clinical Oncology.

[28]  A. Labanaris,et al.  The role of conventional and functional endorectal magnetic resonance imaging in the decision of whether to preserve or resect the neurovascular bundles during radical retropubic prostatectomy , 2009, Scandinavian journal of urology and nephrology.

[29]  Gabor Fichtinger,et al.  Simultaneous integrated boost of biopsy proven, MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: early results of a phase I NCI study , 2007, Radiation oncology.

[30]  A. Villers,et al.  Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. , 2006, The Journal of urology.

[31]  L. Liberman,et al.  Breast imaging reporting and data system (BI-RADS). , 2002, Radiologic clinics of North America.

[32]  O. Linton,et al.  American College of Radiology , 2018, Definitions.